Intelligent Bio Solutions Inc. announced its financial results for the fiscal third quarter and nine months ended March 31, 2025. Revenue from sales of goods increased by $121,373, or 20%, to $728,867 for the three months ended March 31, 2025, compared to the previous quarter.
Gross profit increased by $162,879, or 91%, to $341,368 for the three months ended March 31, 2025, compared to the same period in 2024. For the nine months, gross profit increased by $301,214, or 49%, to $911,282, mainly due to enhanced production capacity and a strategic shift towards higher-margin cartridge sales, which now represent 58% of total revenue.
The net loss attributable to the company decreased by $434,141 to $2,543,526 for the three months ended March 31, 2025, compared to the same period in 2024. The company added 35 new accounts during the quarter, bringing its total active customer base to over 450, and advanced its international growth strategy with multilingual upgrades and IP protection.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.